Literature DB >> 21708292

Surveillance and molecular characterization of human influenza B viruses during 2006-2010 revealed co-circulation of Yamagata-like and Victoria-like strains in eastern India.

Tapasi Roy1, Anurodh S Agrawal, Anupam Mukherjee, Akhilesh C Mishra, Mandeep S Chadha, Harpreet Kaur, Mamta Chawla-Sarkar.   

Abstract

Acute respiratory illness (ARI) is one of the major health problems in tropical countries of Asia, like India where approximately 0.5 million children in the age group of < 5 years die annually. Previously we have reported the genetic characterization of influenza A (Inf-A) strains circulating in Kolkata, eastern India. This study was initiated to characterize the genetic diversity of the circulating influenza B (Inf-B) viruses. Of 3035 nasal/throat swabs, 494 (16.3%) samples were identified as influenza A/B positive by real time RT-PCR, of which 244 samples were confirmed having Inf-B infection. Comparison of nucleotide (nt) and amino acid (aa) sequences of HA and NA gene of Inf-B viruses revealed co-circulation of B/Yamagata and B/Victoria lineages. Of the 32 randomly selected Inf-B strains from Kolkata, seventeen strains possessed reassorted NA gene. There was a single Histidine to Asparagine substitution in the 131st position which is a part of 120 loop on HA1 region along with a deletion at position 178 in the Kolkata strains belonging to the Yamagata lineage. Amino acid substitution was observed at position 198 on NA gene in the strains B/Kol/542/2006, B/Kol/1373/2008, B/Kol/1880/2008, B/Kol/2044/2008 and in all the representative strains isolated during 2009 with respect to the circulating vaccine strains. This substitution is responsible for reduced sensitivity of neuraminidase inhibitors. The results highlight the importance of monitoring Inf-B viruses for development of antiviral resistance among circulating strains.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21708292     DOI: 10.1016/j.meegid.2011.05.022

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  11 in total

Review 1.  Neuraminidase inhibitors for influenza B virus infection: efficacy and resistance.

Authors:  Andrew J Burnham; Tatiana Baranovich; Elena A Govorkova
Journal:  Antiviral Res       Date:  2013-09-04       Impact factor: 5.970

2.  Influenza B in a temperate region of northern India 2010-2016: co-circulation of the two lineages with northern hemispherical seasonality.

Authors:  Parvaiz A Koul; Varsha Potdar; Masooma Showkat; Hyder Mir; M S Chadha
Journal:  Virusdisease       Date:  2018-09-26

3.  Trends of influenza B during the 2010-2016 seasons in 2 regions of north and south Italy: The impact of the vaccine mismatch on influenza immunisation strategy.

Authors:  Andrea Orsi; Giuseppina Maria Elena Colomba; Fanny Pojero; Giuseppe Calamusa; Cristiano Alicino; Cecilia Trucchi; Paola Canepa; Filippo Ansaldi; Francesco Vitale; Fabio Tramuto
Journal:  Hum Vaccin Immunother       Date:  2017-08-03       Impact factor: 3.452

4.  Molecular characterization of influenza B viruses isolated in east-central China in 2009-2010.

Authors:  Na Zhu; Peng Li; Jingfeng Yu; Yongdong Li; Jiuru Zhao; Han Xia; Shuang Tang; Zhong Zhang; Zheng Kou; Shiyu Yin; Zhaojun Fan; Tianxian Li
Journal:  Virus Genes       Date:  2012-09-26       Impact factor: 2.332

5.  Full genomic analysis of an influenza A (H1N2) virus identified during 2009 pandemic in Eastern India: evidence of reassortment event between co-circulating A(H1N1)pdm09 and A/Brisbane/10/2007-like H3N2 strains.

Authors:  Tapasi Roy Mukherjee; Anurodh S Agrawal; Sekhar Chakrabarti; Mamta Chawla-Sarkar
Journal:  Virol J       Date:  2012-10-11       Impact factor: 4.099

6.  Simplified large-scale Sanger genome sequencing for influenza A/H3N2 virus.

Authors:  Hong Kai Lee; Julian Wei-Tze Tang; Debra Han-Lin Kong; Evelyn Siew-Chuan Koay
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  Immunogenicity and safety assessment of a trivalent, inactivated split influenza vaccine in Korean children: Double-blind, randomized, active-controlled multicenter phase III clinical trial.

Authors:  Seung Beom Han; Jung-Woo Rhim; Hye Jo Shin; Soo Young Lee; Hyun-Hee Kim; Jong-Hyun Kim; Kyung-Yil Lee; Sang Hyuk Ma; Joon Soo Park; Hwang Min Kim; Chun Soo Kim; Dong Ho Kim; Young Youn Choi; Sung-Ho Cha; Young Jin Hong; Jin Han Kang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

8.  Epidemiological and Evolutionary Dynamics of Influenza B Viruses in Malaysia, 2012-2014.

Authors:  Xiang Yong Oong; Kim Tien Ng; Tommy Tsan-Yuk Lam; Yong Kek Pang; Kok Gan Chan; Nik Sherina Hanafi; Adeeba Kamarulzaman; Kok Keng Tee
Journal:  PLoS One       Date:  2015-08-27       Impact factor: 3.240

9.  Genome-wide evolutionary dynamics of influenza B viruses on a global scale.

Authors:  Pinky Langat; Jayna Raghwani; Gytis Dudas; Thomas A Bowden; Stephanie Edwards; Astrid Gall; Trevor Bedford; Andrew Rambaut; Rodney S Daniels; Colin A Russell; Oliver G Pybus; John McCauley; Paul Kellam; Simon J Watson
Journal:  PLoS Pathog       Date:  2017-12-28       Impact factor: 6.823

10.  Influenza B associated paediatric acute respiratory infection hospitalization in central vietnam.

Authors:  Keisuke Yoshihara; Minh Nhat Le; Michiko Toizumi; Hien Anh Nguyen; Hien Minh Vo; Takato Odagiri; Seiichiro Fujisaki; Koya Ariyoshi; Hiroyuki Moriuchi; Masahiro Hashizume; Duc Anh Dang; Lay-Myint Yoshida
Journal:  Influenza Other Respir Viruses       Date:  2019-02-28       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.